Evidence map›Paper›PMID 37755555›Full record

ArticlePediatric surgery international2023

Present state of intestinal transplantation in Japan.

Takehisa Ueno, Motoshi Wada, Eri Ogawa, Toshiharu Matsuura, Yohei Yamada, Seisuke Sakamoto, Hiroomi Okuyama

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pediatric surgery international, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 6 institutions in 1 country.

Takehisa UenoDepartment of Pediatric Surgery, Osaka University of Graduation School of Medicine, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan. ueno@pedsurg.med.osaka-u.ac.jp.
Motoshi WadaDepartment of Pediatric Surgery, Tohoku University Graduate School of Medicine, 1-1 Seiryo-cho Aoba-ku, Sendai-shi, Miyagi-ken, Japan.
Eri OgawaDepartment of Surgery, Kyoto University Graduate School of Medicine, Yoshida-Konoe-cho, Sakyo-ku, Kyoto, 606-8501, Japan.
Toshiharu MatsuuraDepartment of Pediatric Surgery, Graduate School of Medical Sciences, Kyushu University, 744 Motooka, Nishi-ku, Fukuoka, Japan.
Yohei YamadaDepartment of Pediatric Surgery/Transplant Center, Keio University School of Medicine, 35 Shinanomachi, Shinjuku, Tokyo, 160-8582, Japan.
Seisuke SakamotoOrgan Transplantation Center, National Center for Child Health and Development, 2-10-1 Okura, Setagaya-ku, Tokyo, 157-8535, Japan.
Hiroomi OkuyamaDepartment of Pediatric Surgery, Osaka University of Graduation School of Medicine, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan.
Osaka University · JPKeio University · JPKyoto University · JPKyushu University · JPNational Center For Child Health and Development · JPTohoku University · JP

Funding

Wellcome Trust FC001042
6 · The paper itself

Abstract

introductionIntestinal transplantation (ITx) is the ultimate treatment for intestinal failure (IF). In Japan, most cases of IF are a result of pediatric disease, including secondary or congenital intestinal disease or allied disorders of Hirschsprung's disease. Here, we report the results of the Japanese ITx registry.

methodsA web-based survey form was completed. We investigated the number, age, sex, indication, surgical procedure, immunosuppressants, postoperative course, and the effects of transplantation in patients who underwent cadaveric or living-donor ITx.

resultsBy the end of 2022, 42 cases of ITx have been performed in 38 patients in Japan. The donor sources included cadavers (29 cases) and living donors (13 cases). The surgical method was isolated ITx (N = 40) and combined liver and ITx (n = 2). Survival rates were 92%, 73%, and 59% at 1 year, 5 years, and 10 years, respectively. Ninety percent of patients completely discontinued parenteral nutrition. Approximately 80% of the patients had a performance status of 1 or less, indicating that the QOL of patients after ITx was extremely good.

conclusionThe results of ITx are acceptable to treat IF patients and the QOL after transplantation is also good.

Indexed as

Intestinal DiseasesShort Bowel SyndromeChildHumansIntestinesJapanLiving DonorsQuality of LifeRetrospective StudiesEverolimusIntestinal failureMotility disorderParental nutritionShort bowel syndromeSmall bowel transplantation

Identifiers

PMID37755555
PMCPMC10533569
OpenAlexW4387077631

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.